Guo D F, Uno S, Ishihata A, Nakamura N, Inagami T
Department of Biochemistry, Vanderbilt University, School of Medicine, Nashville, TN 37232, USA.
Circ Res. 1995 Aug;77(2):249-57. doi: 10.1161/01.res.77.2.249.
Enhanced vascular responsiveness to angiotensin II at the AT1 receptor has been considered one of the major contributing factors to vascular hypertrophy and high blood pressure. The transcription of the rat angiotensin II type 1A receptor gene is stimulated by glucocorticoids. To clarify the molecular mechanism for glucocorticoid action in rat vascular smooth muscle cells, we investigated the effects of dexamethasone on the promoter activity of the angiotensin II type 1A receptor by using promoter/luciferase reporter gene constructs and heterologous context constructs (containing the thymidine kinase promoter) in transfected vascular smooth muscle cells (< 12 passages). There are three putative glucocorticoid responsive elements (GREs) in the promoter. However, only one GRE was found to respond to dexamethasone (1 mumol/L) and was located at positions -756 to -770 bp upstream from the transcription initiation site. When compared with the consensus sequence of GRE, 9 of 12 bases were identical. RU38486, a glucocorticoid antagonist, completely blocked the induction by dexamethasone, suggesting that the GRE was functional through a specific glucocorticoid receptor. The response to dexamethasone was lost in vascular smooth muscle cells at higher passage numbers (> 8 passages) but was restored when the cells were transfected with a glucocorticoid-receptor expression construct. This finding provided additional support that the response to dexamethasone was mediated by the glucocorticoid receptor. The gel mobility supershift assay showed that the GRE binds in vitro-translated rat glucocorticoid receptors in a specific manner. Compared with the angiotensin II type 1A receptor promoter, no effect by dexamethasone was observed in vascular smooth muscle cells transfected with the angiotensin II type 1B receptor promoter/luciferase reporter gene constructs.(ABSTRACT TRUNCATED AT 250 WORDS)
血管对血管紧张素II在AT1受体处的反应性增强被认为是导致血管肥厚和高血压的主要因素之一。大鼠血管紧张素II 1A型受体基因的转录受糖皮质激素刺激。为阐明糖皮质激素在大鼠血管平滑肌细胞中的作用分子机制,我们在转染的血管平滑肌细胞(传代次数<12次)中,利用启动子/荧光素酶报告基因构建体和异源背景构建体(含胸苷激酶启动子)研究了地塞米松对血管紧张素II 1A型受体启动子活性的影响。该启动子中有三个假定的糖皮质激素反应元件(GREs)。然而,仅发现一个GRE对地塞米松(1μmol/L)有反应,其位于转录起始位点上游-756至-770 bp处。与GRE的共有序列相比,12个碱基中有9个相同。糖皮质激素拮抗剂RU38486完全阻断了地塞米松的诱导作用,提示该GRE通过特异性糖皮质激素受体发挥功能。传代次数较高(>8代)的血管平滑肌细胞对地塞米松的反应消失,但当细胞转染糖皮质激素受体表达构建体时反应恢复。这一发现进一步支持了对地塞米松的反应是由糖皮质激素受体介导的。凝胶迁移超迁移分析表明,GRE以特异性方式与体外翻译的大鼠糖皮质激素受体结合。与血管紧张素II 1A型受体启动子相比,转染血管紧张素II 1B型受体启动子/荧光素酶报告基因构建体的血管平滑肌细胞未观察到地塞米松的作用。(摘要截短于250字)